Theracurmin

Theracurmin

Best for

Ease arthritis pain and joint inflammation

Likely benefit · 120–1500 mg/day for 20–52 weeks · 3 meta-analyses , n=3.4k

21 papers · 6 claims · 67 outcomes scored · 5 positive

Outcomes

What theracurmin actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Ease arthritis pain and joint inflammation Likely benefit
moderate
4 meta-analyses n=3.4k Meta-analyzed 120–1500 mg 20–52 wk #2/21
Loosen stiff joints Likely benefit
moderate
3 meta-analyses n=2.2k Meta-analyzed 120–1500 mg 20 wk #5/9
Reduce everyday pain intensity Likely modest benefit
small
6 meta-analyses n=2.7k Meta-analyzed 120–3000 mg 1–20 wk
Ease rheumatoid arthritis symptoms Likely modest benefit
small
1 meta-analysis n=275 Meta-analyzed 120–1500 mg 20 wk #1/6
Ease indigestion and heartburn Likely modest benefit
small
1 meta-analysis n=110 Meta-analyzed 4 wk #4/11
Build glutathione antioxidant levels Not enough research
1 RCT n=— 750 mg 39 wk

Risk profile

Adverse events and known drug interactions

Safety events

hepatotoxicity_by_usnic_acid severe
gastrointestinal events (bloating, diarrhoea, nausea, abdominal pain, constipation) mild
nausea mild
vomiting mild
stomach pain / dyspepsia / gastro-esophageal reflux mild
meteorism (abdominal bloating) mild
weight gain mild
relapsing rash / itching mild

Want personalized recommendations?

Show me what works for me